Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Filament Health files amended pro forma financial statements

Filament Health Corp (NEO:FH, OTCQB:FLHLF) told investors that it has filed amended pro forma financial statements following its previous press release dated December 6, 2023, related to its proposed business combination.

The company noted in a statement that the amended statements replace the previously filed pro forma financial statements referenced in the press release, which contained an error resulting in certain subscription proceeds being double-counted, in their entirety.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK